Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)
The study analyzes the current status of personalized medicine in pediatric oncology in Spain. It gathers national data on the tumor molecular studies and genomic sequencing carried out at diagnosis and at relapse, the centers that perform these studies, the technology used and the interpretation an...
Gespeichert in:
| Veröffentlicht in: | Clinical & translational oncology 2022-05, Vol.24 (5), p.809-815 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 815 |
|---|---|
| container_issue | 5 |
| container_start_page | 809 |
| container_title | Clinical & translational oncology |
| container_volume | 24 |
| creator | Gargallo, P. Bautista, F. Juan-Ribelles, A. Izquierdo, E. Soriano, A. de Rojas, T. Escudero, A. Lavarino, C. Solano, P. Hladun, R. Rubio-San-Simón, A. Martínez-Romera, I. Calabria, I. Olaciregui, N. G. Castañeda-Heredia, A. de Álava, E. Pérez-Martínez, A. Astigarraga, I. Patiño-García, A. Alonso, J. Fernández-Teijeiro, A. Cañete, A. Moreno, L. |
| description | The study analyzes the current status of personalized medicine in pediatric oncology in Spain. It gathers national data on the tumor molecular studies and genomic sequencing carried out at diagnosis and at relapse, the centers that perform these studies, the technology used and the interpretation and clinical applicability of the results. Current challenges and future directions to achieve a coordinated national personalized medicine strategy in pediatric oncology are also discussed. Next generation sequencing-based (NGS) gene panels are the technology used in the majority of centers and financial limitations are the main reason for not incorporating these studies into routine care. Nowadays, the application of precision medicine in pediatric oncology is a reality in a great number of Spanish centers. However, its implementation is uneven and lacks standardization of protocols; therefore, national coordination to overcome the inequalities is required. Collaborative work within the Personalized Medicine Group of SEHOP is an adequate framework for encouraging a step forward in the effort to move precision medicine into the national healthcare system. |
| doi_str_mv | 10.1007/s12094-021-02759-7 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2628683061</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2628683061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-c8834aceb5a4b970b9c0217aad4470d2885f18d0057c2994b47ce39277ad581c3</originalsourceid><addsrcrecordid>eNp9kc1OxCAUhYnR-P8CLgxLXVT5aUtxZybqmJiMyeiaUHpHMTNQgS7mYXxXGavGlQvCCZz75d57EDqh5IISIi4jZUSWBWE0H1HJQmyhfVpLWXBSVdt_9B46iPGNZFVTuov2eEUrxutyH31MhhDAJRyTTkPEfoH7AMZG6x1eQWeNdYCtw33WOgVrsHfGL_3LevM677V1V1hj410EFzMhQO9Dwu0ap1fYGJyNr3jujYW03vAf9S9qqmGl00jTrsOzH_TZ_GY6ezw_QjsLvYxw_H0foufbm6fJtHiY3d1Prh8KwyVNhWkaXmoDbaXLVgrSSpOXIrTuylKQjjVNtaBNl-cXhklZtqUwwCUTQndVQw0_RGcjtw_-fYCY1MpGA8ulduCHqFjNmrrhpKbZykarCT7GAAvVB7vSYa0oUZtY1BiLyh2or1iUyEWn3_yhzUv9LfnJIRv4aIj5y71AUG9-CC7P_B_2E60Xmek</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2628683061</pqid></control><display><type>article</type><title>Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Gargallo, P. ; Bautista, F. ; Juan-Ribelles, A. ; Izquierdo, E. ; Soriano, A. ; de Rojas, T. ; Escudero, A. ; Lavarino, C. ; Solano, P. ; Hladun, R. ; Rubio-San-Simón, A. ; Martínez-Romera, I. ; Calabria, I. ; Olaciregui, N. G. ; Castañeda-Heredia, A. ; de Álava, E. ; Pérez-Martínez, A. ; Astigarraga, I. ; Patiño-García, A. ; Alonso, J. ; Fernández-Teijeiro, A. ; Cañete, A. ; Moreno, L.</creator><creatorcontrib>Gargallo, P. ; Bautista, F. ; Juan-Ribelles, A. ; Izquierdo, E. ; Soriano, A. ; de Rojas, T. ; Escudero, A. ; Lavarino, C. ; Solano, P. ; Hladun, R. ; Rubio-San-Simón, A. ; Martínez-Romera, I. ; Calabria, I. ; Olaciregui, N. G. ; Castañeda-Heredia, A. ; de Álava, E. ; Pérez-Martínez, A. ; Astigarraga, I. ; Patiño-García, A. ; Alonso, J. ; Fernández-Teijeiro, A. ; Cañete, A. ; Moreno, L.</creatorcontrib><description>The study analyzes the current status of personalized medicine in pediatric oncology in Spain. It gathers national data on the tumor molecular studies and genomic sequencing carried out at diagnosis and at relapse, the centers that perform these studies, the technology used and the interpretation and clinical applicability of the results. Current challenges and future directions to achieve a coordinated national personalized medicine strategy in pediatric oncology are also discussed. Next generation sequencing-based (NGS) gene panels are the technology used in the majority of centers and financial limitations are the main reason for not incorporating these studies into routine care. Nowadays, the application of precision medicine in pediatric oncology is a reality in a great number of Spanish centers. However, its implementation is uneven and lacks standardization of protocols; therefore, national coordination to overcome the inequalities is required. Collaborative work within the Personalized Medicine Group of SEHOP is an adequate framework for encouraging a step forward in the effort to move precision medicine into the national healthcare system.</description><identifier>ISSN: 1699-3055</identifier><identifier>EISSN: 1699-3055</identifier><identifier>DOI: 10.1007/s12094-021-02759-7</identifier><identifier>PMID: 35152364</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Child ; Consensus ; Hematology ; High-Throughput Nucleotide Sequencing ; Humans ; Medicine ; Medicine & Public Health ; Neoplasms - genetics ; Neoplasms - pathology ; Neoplasms - therapy ; Oncology ; Precision Medicine - methods ; Spain ; Special Article</subject><ispartof>Clinical & translational oncology, 2022-05, Vol.24 (5), p.809-815</ispartof><rights>The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO) 2022</rights><rights>2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-c8834aceb5a4b970b9c0217aad4470d2885f18d0057c2994b47ce39277ad581c3</citedby><cites>FETCH-LOGICAL-c391t-c8834aceb5a4b970b9c0217aad4470d2885f18d0057c2994b47ce39277ad581c3</cites><orcidid>0000-0001-9720-8542</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12094-021-02759-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12094-021-02759-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35152364$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gargallo, P.</creatorcontrib><creatorcontrib>Bautista, F.</creatorcontrib><creatorcontrib>Juan-Ribelles, A.</creatorcontrib><creatorcontrib>Izquierdo, E.</creatorcontrib><creatorcontrib>Soriano, A.</creatorcontrib><creatorcontrib>de Rojas, T.</creatorcontrib><creatorcontrib>Escudero, A.</creatorcontrib><creatorcontrib>Lavarino, C.</creatorcontrib><creatorcontrib>Solano, P.</creatorcontrib><creatorcontrib>Hladun, R.</creatorcontrib><creatorcontrib>Rubio-San-Simón, A.</creatorcontrib><creatorcontrib>Martínez-Romera, I.</creatorcontrib><creatorcontrib>Calabria, I.</creatorcontrib><creatorcontrib>Olaciregui, N. G.</creatorcontrib><creatorcontrib>Castañeda-Heredia, A.</creatorcontrib><creatorcontrib>de Álava, E.</creatorcontrib><creatorcontrib>Pérez-Martínez, A.</creatorcontrib><creatorcontrib>Astigarraga, I.</creatorcontrib><creatorcontrib>Patiño-García, A.</creatorcontrib><creatorcontrib>Alonso, J.</creatorcontrib><creatorcontrib>Fernández-Teijeiro, A.</creatorcontrib><creatorcontrib>Cañete, A.</creatorcontrib><creatorcontrib>Moreno, L.</creatorcontrib><title>Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)</title><title>Clinical & translational oncology</title><addtitle>Clin Transl Oncol</addtitle><addtitle>Clin Transl Oncol</addtitle><description>The study analyzes the current status of personalized medicine in pediatric oncology in Spain. It gathers national data on the tumor molecular studies and genomic sequencing carried out at diagnosis and at relapse, the centers that perform these studies, the technology used and the interpretation and clinical applicability of the results. Current challenges and future directions to achieve a coordinated national personalized medicine strategy in pediatric oncology are also discussed. Next generation sequencing-based (NGS) gene panels are the technology used in the majority of centers and financial limitations are the main reason for not incorporating these studies into routine care. Nowadays, the application of precision medicine in pediatric oncology is a reality in a great number of Spanish centers. However, its implementation is uneven and lacks standardization of protocols; therefore, national coordination to overcome the inequalities is required. Collaborative work within the Personalized Medicine Group of SEHOP is an adequate framework for encouraging a step forward in the effort to move precision medicine into the national healthcare system.</description><subject>Child</subject><subject>Consensus</subject><subject>Hematology</subject><subject>High-Throughput Nucleotide Sequencing</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neoplasms - genetics</subject><subject>Neoplasms - pathology</subject><subject>Neoplasms - therapy</subject><subject>Oncology</subject><subject>Precision Medicine - methods</subject><subject>Spain</subject><subject>Special Article</subject><issn>1699-3055</issn><issn>1699-3055</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1OxCAUhYnR-P8CLgxLXVT5aUtxZybqmJiMyeiaUHpHMTNQgS7mYXxXGavGlQvCCZz75d57EDqh5IISIi4jZUSWBWE0H1HJQmyhfVpLWXBSVdt_9B46iPGNZFVTuov2eEUrxutyH31MhhDAJRyTTkPEfoH7AMZG6x1eQWeNdYCtw33WOgVrsHfGL_3LevM677V1V1hj410EFzMhQO9Dwu0ap1fYGJyNr3jujYW03vAf9S9qqmGl00jTrsOzH_TZ_GY6ezw_QjsLvYxw_H0foufbm6fJtHiY3d1Prh8KwyVNhWkaXmoDbaXLVgrSSpOXIrTuylKQjjVNtaBNl-cXhklZtqUwwCUTQndVQw0_RGcjtw_-fYCY1MpGA8ulduCHqFjNmrrhpKbZykarCT7GAAvVB7vSYa0oUZtY1BiLyh2or1iUyEWn3_yhzUv9LfnJIRv4aIj5y71AUG9-CC7P_B_2E60Xmek</recordid><startdate>20220501</startdate><enddate>20220501</enddate><creator>Gargallo, P.</creator><creator>Bautista, F.</creator><creator>Juan-Ribelles, A.</creator><creator>Izquierdo, E.</creator><creator>Soriano, A.</creator><creator>de Rojas, T.</creator><creator>Escudero, A.</creator><creator>Lavarino, C.</creator><creator>Solano, P.</creator><creator>Hladun, R.</creator><creator>Rubio-San-Simón, A.</creator><creator>Martínez-Romera, I.</creator><creator>Calabria, I.</creator><creator>Olaciregui, N. G.</creator><creator>Castañeda-Heredia, A.</creator><creator>de Álava, E.</creator><creator>Pérez-Martínez, A.</creator><creator>Astigarraga, I.</creator><creator>Patiño-García, A.</creator><creator>Alonso, J.</creator><creator>Fernández-Teijeiro, A.</creator><creator>Cañete, A.</creator><creator>Moreno, L.</creator><general>Springer International Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9720-8542</orcidid></search><sort><creationdate>20220501</creationdate><title>Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)</title><author>Gargallo, P. ; Bautista, F. ; Juan-Ribelles, A. ; Izquierdo, E. ; Soriano, A. ; de Rojas, T. ; Escudero, A. ; Lavarino, C. ; Solano, P. ; Hladun, R. ; Rubio-San-Simón, A. ; Martínez-Romera, I. ; Calabria, I. ; Olaciregui, N. G. ; Castañeda-Heredia, A. ; de Álava, E. ; Pérez-Martínez, A. ; Astigarraga, I. ; Patiño-García, A. ; Alonso, J. ; Fernández-Teijeiro, A. ; Cañete, A. ; Moreno, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-c8834aceb5a4b970b9c0217aad4470d2885f18d0057c2994b47ce39277ad581c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Child</topic><topic>Consensus</topic><topic>Hematology</topic><topic>High-Throughput Nucleotide Sequencing</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neoplasms - genetics</topic><topic>Neoplasms - pathology</topic><topic>Neoplasms - therapy</topic><topic>Oncology</topic><topic>Precision Medicine - methods</topic><topic>Spain</topic><topic>Special Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gargallo, P.</creatorcontrib><creatorcontrib>Bautista, F.</creatorcontrib><creatorcontrib>Juan-Ribelles, A.</creatorcontrib><creatorcontrib>Izquierdo, E.</creatorcontrib><creatorcontrib>Soriano, A.</creatorcontrib><creatorcontrib>de Rojas, T.</creatorcontrib><creatorcontrib>Escudero, A.</creatorcontrib><creatorcontrib>Lavarino, C.</creatorcontrib><creatorcontrib>Solano, P.</creatorcontrib><creatorcontrib>Hladun, R.</creatorcontrib><creatorcontrib>Rubio-San-Simón, A.</creatorcontrib><creatorcontrib>Martínez-Romera, I.</creatorcontrib><creatorcontrib>Calabria, I.</creatorcontrib><creatorcontrib>Olaciregui, N. G.</creatorcontrib><creatorcontrib>Castañeda-Heredia, A.</creatorcontrib><creatorcontrib>de Álava, E.</creatorcontrib><creatorcontrib>Pérez-Martínez, A.</creatorcontrib><creatorcontrib>Astigarraga, I.</creatorcontrib><creatorcontrib>Patiño-García, A.</creatorcontrib><creatorcontrib>Alonso, J.</creatorcontrib><creatorcontrib>Fernández-Teijeiro, A.</creatorcontrib><creatorcontrib>Cañete, A.</creatorcontrib><creatorcontrib>Moreno, L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical & translational oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gargallo, P.</au><au>Bautista, F.</au><au>Juan-Ribelles, A.</au><au>Izquierdo, E.</au><au>Soriano, A.</au><au>de Rojas, T.</au><au>Escudero, A.</au><au>Lavarino, C.</au><au>Solano, P.</au><au>Hladun, R.</au><au>Rubio-San-Simón, A.</au><au>Martínez-Romera, I.</au><au>Calabria, I.</au><au>Olaciregui, N. G.</au><au>Castañeda-Heredia, A.</au><au>de Álava, E.</au><au>Pérez-Martínez, A.</au><au>Astigarraga, I.</au><au>Patiño-García, A.</au><au>Alonso, J.</au><au>Fernández-Teijeiro, A.</au><au>Cañete, A.</au><au>Moreno, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)</atitle><jtitle>Clinical & translational oncology</jtitle><stitle>Clin Transl Oncol</stitle><addtitle>Clin Transl Oncol</addtitle><date>2022-05-01</date><risdate>2022</risdate><volume>24</volume><issue>5</issue><spage>809</spage><epage>815</epage><pages>809-815</pages><issn>1699-3055</issn><eissn>1699-3055</eissn><abstract>The study analyzes the current status of personalized medicine in pediatric oncology in Spain. It gathers national data on the tumor molecular studies and genomic sequencing carried out at diagnosis and at relapse, the centers that perform these studies, the technology used and the interpretation and clinical applicability of the results. Current challenges and future directions to achieve a coordinated national personalized medicine strategy in pediatric oncology are also discussed. Next generation sequencing-based (NGS) gene panels are the technology used in the majority of centers and financial limitations are the main reason for not incorporating these studies into routine care. Nowadays, the application of precision medicine in pediatric oncology is a reality in a great number of Spanish centers. However, its implementation is uneven and lacks standardization of protocols; therefore, national coordination to overcome the inequalities is required. Collaborative work within the Personalized Medicine Group of SEHOP is an adequate framework for encouraging a step forward in the effort to move precision medicine into the national healthcare system.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>35152364</pmid><doi>10.1007/s12094-021-02759-7</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-9720-8542</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1699-3055 |
| ispartof | Clinical & translational oncology, 2022-05, Vol.24 (5), p.809-815 |
| issn | 1699-3055 1699-3055 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2628683061 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Child Consensus Hematology High-Throughput Nucleotide Sequencing Humans Medicine Medicine & Public Health Neoplasms - genetics Neoplasms - pathology Neoplasms - therapy Oncology Precision Medicine - methods Spain Special Article |
| title | Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T18%3A15%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20status%20of%20precision%20medicine%20in%20pediatric%20oncology%20in%20Spain:%20a%20consensus%20report%20by%20the%20Spanish%20Society%20of%20Paediatric%20Haematology%20and%20Oncology%20(SEHOP)&rft.jtitle=Clinical%20&%20translational%20oncology&rft.au=Gargallo,%20P.&rft.date=2022-05-01&rft.volume=24&rft.issue=5&rft.spage=809&rft.epage=815&rft.pages=809-815&rft.issn=1699-3055&rft.eissn=1699-3055&rft_id=info:doi/10.1007/s12094-021-02759-7&rft_dat=%3Cproquest_cross%3E2628683061%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2628683061&rft_id=info:pmid/35152364&rfr_iscdi=true |